StockData
SkinHealth Systems Inc. logo

SkinHealth Systems Inc. (SKIN) stock

SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3050% below fair value
$16.31+0.35 (+2.19%)

Close on Nov 13, 2026Market cap $106.23MP/E –Yield –

SkinHealth Systems Inc. saw revenue fall 4.4% to $288.56M over the twelve months to Sep 30, 2026. Free cash flow was $22.69M, down 41.1% from a year earlier. At the latest close the market valued the company at $106.23M.

Revenue
$288.56M
-4.4% vs. a year earlier
Operating income
$6.91M
TTM Q3 2026
Free cash flow
$22.69M
-41.1% vs. a year earlier
EPS, diluted
-$3.20
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$106.23M
P/E ratio
–
Price to sales
0.37
Price to book
1.91
Dividend yield
–
Free cash flow yield
21.36%

Fundamentals

Revenue
$288.56M
Net income
-$18.29M
EPS, diluted
-$3.20
Free cash flow
$22.69M
Book value per share
$8.56
Diluted shares
7M

Trading

Next earnings
Mar 11, 2027 (estimated, after the close)
Previous close
$15.96
Open
$15.75
Day's range
$15.27 – $16.64
Volume
86,337
Average volume (20 days)
75,214
Beta (5 years)
1.60
52-week range
$9.68 – $33.00
RSI (14 days)
67.1
Volatility (1 year)
110.6%
Relative volume
2.25×
WACC
13.1%

On 1 of our idea list: More cash than they're worth

Market cap history

Month-end market cap since 2020, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodSKINS&P 500DifferenceSKIN per yearS&P 500 per year
1 month+50.9%-3.0%+53.9 pts
3 months+23.6%-2.8%+26.3 pts
Year to date-41.3%+11.5%−52.8 pts
1 year-37.3%+13.5%−50.7 pts
3 years-79.1%+77.7%−156.8 pts-40.6%+21.1%
5 years-96.9%+72.6%−169.5 pts-50.1%+11.5%
10 years-98.2%+308.2%−406.3 pts-32.9%+15.1%

Eight years at a glance

Fiscal years 2018 to 2025 and trailing twelve months, USD

Revenue

$288.56M-4.4% YoY

Gross profit

$193.96M-0.9% YoY

Operating income

$6.91M

Net income

-$18.29M

EPS, diluted

–

Free cash flow

$22.69M-41.1% YoY
Reported periodTrailing twelve months

Press releases

Releases SkinHealth Systems filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About SkinHealth Systems

Surgical & Medical Instruments & Apparatus

The Beauty Health Company is a global medical aesthetics company focused on skin health solutions. Its core offering is Hydrafacial, a patented hydradermabrasion system that cleanses, exfoliates, extracts, and hydrates the skin using delivery devices alongside consumable treatment tips, solutions, and booster serums. The company also provides the HydraScalp system for scalp care and the SkinStylus microneedling and nano-channeling system for skin and scar treatments. The company serves providers across the professional medical market, such as dermatologists, plastic surgeons, and medical spas, as well as estheticians and beauty retail spas.

Company profile, executives and history

SkinHealth Systems stock: common questions

What is SkinHealth Systems's stock price?

SKIN closed at $16.31 on Nov 13, 2026, up 2.19% on the day. Over the past 52 weeks it traded between $9.68 and $33.00.

What is SkinHealth Systems's market cap?

SkinHealth Systems was worth $106.23M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.

What is SKIN's P/E ratio?

SkinHealth Systems lost money over fiscal 2025 (diluted EPS -$3.20), so it has no meaningful P/E ratio.

How much revenue does SkinHealth Systems make?

SkinHealth Systems reported revenue of $288.56M for the twelve months to Sep 30, 2026, down 4.4% from a year earlier.

Does SkinHealth Systems pay a dividend?

No. SkinHealth Systems has not paid a cash dividend over the last twelve months.

When does SkinHealth Systems report earnings next?

SkinHealth Systems is expected to report Q4 FY2026 results on Mar 11, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has SKIN stock performed over the past year?

Including dividends, SKIN returned -37.3% over the past year, against +13.5% for the S&P 500.

Who are SkinHealth Systems's competitors?

Companies most similar to SkinHealth Systems by business, industry and size include PRCT, INMD, MDXG, LMAT, ANGO.

See a number that looks wrong?